StockData
Gevo, Inc. logo

Gevo, Inc. (GEVO) stock

GEVONasdaqIndustrial Organic ChemicalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3032% below fair value
$1.64−0.10 (-5.75%)

Close on Nov 17, 2026Market cap $405.47MP/E –Yield –

Gevo r&d expenses

Research and development expenses are spending on new products and technology.

Gevo's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.50M, up 3.0% year over year. For fiscal 2025 it was $4.55M, down 18.4% from the year before. Over ten years it grew -3.7% a year on average. The highest annual figure on record is $20.18M in fiscal 2013.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.55M-18.4%
FY2024Dec 31, 2024$5.58M-16.0%
FY2023Dec 31, 2023$6.64M-10.6%
FY2022Dec 31, 2022$7.43M+9.6%
FY2021Dec 31, 2021$6.78M+93.0%
FY2020Dec 31, 2020$3.51M-9.2%
FY2019Dec 31, 2019$3.87M-28.0%
FY2018Dec 31, 2018$5.37M+3.7%
FY2017Dec 31, 2017$5.18M-0.7%
FY2016Dec 31, 2016$5.22M-21.1%
FY2015Dec 31, 2015$6.61M-53.2%
FY2014Dec 31, 2014$14.12M-30.0%
FY2013Dec 31, 2013$20.18M+3.8%
FY2012Dec 31, 2012$19.43M-1.6%
FY2011Dec 31, 2011$19.75M+33.3%
FY2010Dec 31, 2010$14.82M+41.0%
FY2009Dec 31, 2009$10.51M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$440.00K-52.9%
Q1 FY2026Mar 31, 2026$1.50M+42.5%
Q4 FY2025Dec 31, 2025$1.29M+1.3%
Q3 FY2025Sep 30, 2025$1.27M+14.4%
Q2 FY2025Jun 30, 2025$934.00K-43.1%
Q1 FY2025Mar 31, 2025$1.05M-32.0%
Q4 FY2024Dec 31, 2024$1.27M-33.7%
Q3 FY2024Sep 30, 2024$1.11M-28.6%
Q2 FY2024Jun 30, 2024$1.64M-16.3%
Q1 FY2024Mar 31, 2024$1.55M+29.2%
Q4 FY2023Dec 31, 2023$1.92M-29.0%
Q3 FY2023Sep 30, 2023$1.56M-0.3%
Q2 FY2023Jun 30, 2023$1.96M-0.3%
Q1 FY2023Mar 31, 2023$1.20M+0.5%
Q4 FY2022Dec 31, 2022$2.71M+5.3%
Q3 FY2022Sep 30, 2022$1.56M+4.5%
Q2 FY2022Jun 30, 2022$1.97M+47.6%
Q1 FY2022Mar 31, 2022$1.19M-13.5%
Q4 FY2021Dec 31, 2021$2.57M+85.7%
Q3 FY2021Sep 30, 2021$1.50M+71.8%
Q2 FY2021Jun 30, 2021$1.33M+96.8%
Q1 FY2021Mar 31, 2021$1.38M+137.6%
Q4 FY2020Dec 31, 2020$1.38M+787.2%
Q3 FY2020Sep 30, 2020$870.00K-51.4%
Q2 FY2020Jun 30, 2020$677.00K-28.4%
Q1 FY2020Mar 31, 2020$580.00K-40.7%
Q4 FY2019Dec 31, 2019$156.00K-87.5%
Q3 FY2019Sep 30, 2019$1.79M-4.1%
Q2 FY2019Jun 30, 2019$945.00K-35.7%
Q1 FY2019Mar 31, 2019$978.00K+24.0%
Q4 FY2018Dec 31, 2018$1.25M+44.8%
Q3 FY2018Sep 30, 2018$1.87M+54.1%
Q2 FY2018Jun 30, 2018$1.47M-22.3%
Q1 FY2018Mar 31, 2018$789.00K-35.2%
Q4 FY2017Dec 31, 2017$864.00K-44.1%
Q3 FY2017Sep 30, 2017$1.21M+4.7%
Q2 FY2017Jun 30, 2017$1.89M–
Q1 FY2017Mar 31, 2017$1.22M–
Q4 FY2016Dec 31, 2016$1.55M–
Q3 FY2016Sep 30, 2016$1.16M–

More Gevo figures

See a number that looks wrong?